BRANFORD, Conn., Sept. 11 /PRNewswire-FirstCall/ -- Neurogen Corporation (Nasdaq: NRGN - News), a drug discovery and development company, announced today that William H. Koster, President and CEO, will present a Company overview and pipeline update at the Merriman Curhan Ford Third Annual Investor Summit on Monday, September 18 at 9:00 a.m. PT/12:00 p.m. ET.
